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Abstract: Intracellular lipid-binding proteins are a family of low-molecular-
weight single-chain polypeptides that form 1:1 complexes with fatty acids, ret-
inoids, or other hydrophobic ligands. These proteins are products of a large 
multigene family of unlinked loci distributed throughout the genome. Each 
lipid-binding protein exhibits a distinctive pattern of tissue distribution. Tran-
scriptional control, regulated by a combination of peroxisome proliferator acti-
vated receptors and CCAAT/enhancer-binding proteins, allows for a variety of 
both cell and tissue-specific expression patterns. In some cells, fatty acids in-
crease the expression of the lipid-binding protein genes. Fatty acids, or their me-
tabolites, are activators of the peroxisome proliferator–activated receptor family 
of transcription factors. Therefore, as the concentration of lipid in the diet in-
creases, the expression of lipid-binding proteins coordinately increases. As re-
vealed by X-ray crystallography, the lipid-binding proteins fold into β-barrels, 
forming a large internal water-filled cavity. Fatty acid ligands are bound within 
the cavity, occupying only about one-third of the accessible volume. The bound 
fatty acid is stabilized via a combination of enthalpic and entropic forces that 
govern ligand affinity and selectivity. Cytoplasmic lipid-binding proteins are the 
intracellular receptors for hydrophobic ligands, delivering them to the appropri-
ate site for use as metabolic fuels and regulatory agents. 
Keywords: fatty acids, carrier proteins, peroxisome proliferator–activated re-
ceptors, dietary fat, gene expression 
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INTRODUCTION 
Ockner et al’s 1972 paper entitled “A binding protein for fatty acids in cy-
tosol of intestinal mucosa, liver, myocardium, and other tissues” (81) is gen-
erally credited with providing the impetus for studies of the structure, func-
tion, and regulation of the intracellular lipid-binding protein multigene family. 
Some 25 years later, the number of contributions to the literature has grown 
to 1500. The diversity of topics ranges from high-resolution X-ray crystal-
lographic analysis of the fatty acid–binding proteins and the role(s) of weak 
forces in lipid binding to molecular genetic studies of the linkage between 
polymorphisms in the intestinal fatty acid–binding protein gene and diabe-
tes. Popular textbooks now contain information concerning intracellular fatty 
acid–binding proteins in lipid metabolism, and scientific meetings are orga-
nized around the topic. 
Because dietary fats typically constitute over 30% of the caloric intake, 
the metabolic relationships between intracellular fatty acid–binding proteins 
and the trafficking of nutritionally derived lipids remains an active area of 
research. The flux of fatty acids into, out of, and between cells is emerging 
as a key facet of information transfer between cells. Fatty acids function not 
only as components of membranes or storage depots but also as critical sig-
naling molecules playing fundamental roles in areas such as differentiation, 
development, and hormone action. Transgenic animals lacking certain fatty 
acid–binding proteins exhibit altered expression of lipid-regulated genes, sug-
gesting the involvement of lipid-binding proteins in signal transduction (42). 
These examples point out the close association between nutrient sensing and 
cytoplasmic carrier proteins of dietary lipids. 
As Ockner’s paper indicated, a variety of tissue and cell types express in-
tracellular lipid-binding proteins. Analysis of the organization of lipid-bind-
ing protein genes indicates an evolutionary relationship among the proteins 
and points toward extensive gene duplication events as the origin of the many 
different family members. To date, at least 23 members of the intracellular 
lipid-binding protein multigene family have been described; some preferen-
tially bind fatty acids or related compounds while others associate with reti-
noids and vitamin A derivatives. To avoid overlap with Li & Norris’s discus-
sion of the intracellular retinoid-binding proteins (69), this review focuses on 
the fatty acid–binding members of the gene family and touches on retinoid-
binding proteins and their genes only as they relate to the fatty acid–binding 
proteins. This review summarizes current knowledge of the structure and ge-
netics of lipid-binding proteins in hopes that it may foster new insights into 
the functional aspects of these fascinating proteins. 
FATTY ACID–BINDING PROTEIN GENE ORGANIZATION 
Genomic Organization and Structure 
Somatic cell hybrids and restriction fragment length polymorphisms 
(RFLP) have been used to determine the chromosome locations of many fatty 
acid–binding protein (FABP) genes (Table 1; see also 12, 36, 39, 82, 86, 112, 
118). At least in humans and mice, the genes encoding FABPs are dispersed 
throughout the genome. There appear to be no linkages between any of the 
genes for fatty acid– and retinoid-binding protein genes. 
The gene structure of the FABP family has been conserved amongst all 
members studied thus far (Figure 1; 33, 45, 78, 87, 114, 118; AV Hertzel, DA 
Bernlohr, manuscript in preparation). Each gene contains four exons separated 
by three introns. Although the length of the introns varies, the length of the ex-
ons has been maintained such that the positions of the introns within the genes 
are essentially identical. Furthermore, this conservation of gene structure for the 
FABPs is also maintained in other members of the lipid-binding protein multi-
gene family. For example, the cellular retinol binding protein and cellular reti-
noic acid binding protein genes all have four exons and three introns, although 
the average length of the introns far exceeds that of the FABP genes (69). 
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Figure 1 Comparison of the structures of the genes for fatty acid–binding proteins. E, Exon; I, in-
tron. The numbers in the boxes indicate the number of amino acids encoded within each exon. 
The bold lines represent the 5′ and 3′ nontranslated portions of exon 1 and exon 4, respectively, 
which are of variable lengths. The intron lengths are in kilobase pairs. ALBP, Murine adipocyte 
LBP (45, 87); IFABP, murine intestinal FABP (33); LFABP, rat liver FABP (114); myelin P2, mu-
rine myelin P2 (78); HFABP, bovine heart FABP (118); KLBP, murine keratinocyte LBP (AV 
Hertzel, DA Bernlohr, manuscript in preparation). 
Most of the FABP genes exist in a single copy in the genome. Presently, 
there are two exceptions: heart HFABP and keratinocyte lipid-binding protein 
(LBP). In humans the heart FABP gene seems to be present in a single copy, 
whereas the murine heart FABP gene is represented three times, once each on 
chromosomes 4, 8, and 10 (39). The copy on chromosome 4 contains three in-
trons, similar to the other FABP genes, and is presumably the functional copy 
(118). The gene on chromosome 10 lacks introns and therefore appears to be 
a pseudogene. The copy on chromosome 8 may represent a related gene (39). 
Southern analysis using the murine keratinocyte LBP cDNA revealed mul-
tiple bands for each restriction endonuclease used, suggesting the presence 
of five to six copies of the keratinocyte LBP gene (60). Only one copy con-
tains a third intron, suggesting a single functional keratinocyte LBP gene (AV 
Hertzel, DA Bernlohr, manuscript in preparation). 
Evolutionary Relationships and Species Considerations 
FABPs have been discovered in many organisms, including humans, cows, 
pigs, mice, rats, rabbits, guinea pigs, fish, chickens, worms, sharks, frogs, and 
insects (121, 125a). The orthologous FABP genes expressed in any given tis-
sue appear to be conserved throughout the various organisms. For exam-
ple, the liver FABPs from mice and humans are more closely related to each 
other than to other mouse and/or human FABPs. One exception is shark liver 
FABP: It appears to resemble rat heart FABP more than rat liver FABP (72). 
The presence of so many different but highly related genes probably origi-
nates from a series of duplications from a common ancestral gene. A complete 
analysis of the evolutionary relatedness of proteins in the FABP family has in-
dicated the relative similarity of these proteins and has identified the positions 
of gene duplications, of which at least 14 appear (101). Only two of these du-
plications took place after the divergence of invertebrates from vertebrates. 
FATTY ACID–BINDING PROTEIN GENE EXPRESSION 
Fatty acid–binding proteins are expressed abundantly (1–5% of cytosolic 
protein) in cells involved in active lipid metabolism. Although all cells require 
fatty acids for membranes, many tissue types such as liver, muscle, and adi-
pose have high flux rates of fatty acids utilized for energy and storage. Mem-
bers of the FABP family exhibit unique tissue-specific expression patterns and 
were named according to the tissue in which each was first identified. Some 
show restricted tissue distribution, whereas others are more widespread. For 
example, adipocyte LBP (10), intestinal FABP (20), epidermal FABP (105), 
myelin P2 (77), brain FABP (62), and testis LBP (also known as PERF15; 83) 
are each expressed in a single tissue. Liver FABP (35, 106, 111), ileal LBP 
(30, 97), and keratinocyte LBP (60) are expressed in a limited number of tis-
sues. Heart FABP (85, 132) exhibits the broadest tissue distribution occurring 
in heart, skeletal muscle, mammary, lung, brain, kidney, testis, ovary, stom-
ach, and adrenal tissues. 
FABP genes are expressed in specific cell types within a tissue(s) as a 
function of the stage of development or differentiation. For example, intesti-
nal FABP has two gradients of expression within the intestine: a vertical gra-
dient (crypt to villus) and a horizontal gradient (duodenal to colon), with the 
highest levels of expression in the jejunum and ileum (33, 121). 
Transcription Factors Affecting FABP Expression 
Peroxisome proliferators are a group of rodent hepatocarcinogens causing 
pleiotropic effects on cell morphology and metabolism. These compounds, 
which include plasticizers, herbicides, and the fibrate class of hypolipidemic 
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drugs, are considered to be nongenotoxic because they fail to damage DNA 
directly. Rather, they may function through an increase in reactive oxygen 
species produced by induction of the H2O2-generating peroxisomal enzymes 
of the fatty acid oxidation system. Peroxisome proliferators act via peroxi-
some proliferator–activated receptors (PPARs), a multigene family that is part 
of the supergene family of nuclear receptors, such as the thyroid hormone, 
retinoic acid, and vitamin D3 receptors (103). There are multiple isoforms of 
PPAR in mice (α, γ , and δ) (133) and in Xenopus laevis (α, β, and γ ) (25, 46). 
Sequence conservation among PPAR isoforms is highest in the DNA-bind-
ing domain, whereas the ligand-binding domain is less well conserved. The 
different PPARs bind to hormone response elements (peroxisome-proliferator 
response elements, PPREs) of the DR-1 class (TGA/TCCT in a direct repeat 
separated by one nucleotide) or to imperfect versions of this element (103). 
Binding affinity may be modified by the sequences that flank these elements 
(84). PPARs are activated by peroxisome proliferators, hypolipidemic drugs, 
and fatty acid metabolites. In a heterologous system using CV1 (monkey kid-
ney) cells, peroxisome proliferators activate PPARα (57). It is thought that 
PPARα is involved in lipid catabolism, whereas PPARγ is involved in lipid 
anabolism; the function of PPARδ is less well characterized (103). 
PPARs bind cooperatively to PPREs as a heterodimer with RXRα (reti-
noid X receptor), thereby activating gene transcription (59). The ligand for 
RXRα is 9-cis retinoic acid. PPARs binds directly to thiazolidinediones (66) 
and 15-deoxyΔ12,14-prostaglandin J2 (27, 58). PPARα binds leukotriene B4 
with an apparent dissociation constant of 90 nM (23a). Simultaneous expo-
sure to a PPAR activator and 9-cis retinoic acid causes synergistic induction 
of gene expression (59). 
Although less well characterized, other nuclear receptors, such as LXRα 
(ligand X receptor), also dimerize with PPARs (74). This dimerization inhib-
its PPAR function by reducing the amount of PPAR/RXR heterodimer. Also, 
unliganded PPAR receptors may bind DNA and inhibit transcription, perhaps 
through co-repressors similar to those that repress the retinoic acid receptor 
and the thyroid hormone receptor (15, 40). 
Each PPAR isoform exhibits a unique tissue-specific expression pattern as a 
result of regulation by various hormones and dietary factors (57). In mice and 
rats, the alpha isoform is expressed in liver, kidney, heart, brain, and gut; gamma 
is highly restricted to adipose tissue; and delta is expressed ubiquitously. In he-
patocytes, steady-state levels of PPARα mRNA are decreased by insulin and 
increased by fatty acids and dexamethasone, although no classical hormone 
response elements appear to be present in the PPAR promoter (68, 109). Fur-
thermore, PPARα is regulated by a diurnal rhythm paralleling that of corticoste-
rone levels (67). Fasting caused an 80% decrease in PPARγ 2 mRNA levels in 
mouse adipocytes, whereas a high-fat diet increased levels by 50% (122). 
Figure 2 Upstream regulatory elements relative to the start of transcription of murine adipocyte 
LBP (ALBP; aP2), intestinal FABP (IFABP), heart FABP (HFABP), and rat liver FABP (LFABP). 
The arrows indicate the position of transcription initiation. The ALBP upstream region contains a 
functional PPAR binding element (DR-1) at −5.3 kb (94, 117), a glucocorticoid response element 
(GRE) at −393 to −385 bp (21), a C/EBPα binding site at −149 to −130 (16), and an AP-1 site at 
−122 to −116 bp (89). Transcription of the LFABP gene is regulated through three C/EBPα bind-
ing sites located at −402 to −385, −356 to −345, and −306 to −275 bp (20, 65). The DR-1 site at 
−75 to −66 bp allows responsiveness to peroxisome proliferators through PPARα (47, 106). IF-
ABP is regulated by C/EBPα at −188 to −167 bp (20) and contains putative DR-1 elements at 
−591 to −579, −430 to −443, and −82 to −69 (33, 112). HFABP’s putative DR-1 site is located at 
−845 bp (118). 
In addition to the PPARs, CCAAT/enhancer-binding proteins (C/EBPs; 
123) are also involved in the regulation of FABP genes. Many of the FABP 
genes contain functional C/EBP-binding sites (Figure 2). C/EBPs comprise 
a family of transcription factors that regulate gene expression through bind-
ing to the DNA sequence ATTGCGCAAT, although significant substitutions 
within this sequence are common (50). These proteins are expressed in tissues 
known to metabolize lipids and cholesterol and are thought to play a global 
role in the regulation of intermediary metabolism. During cellular differenti-
ation, C/EBPs can affect the transcriptional activities of several genes, which 
creates a specialized phenotype leading to the production of a nonproliferat-
ing state (120). Several isoforms have been identified based on comparison of 
their C-terminal DNA-binding domains (125). This region contains the classi-
cal basic region/leucine zipper (bZIP) motif, which allows homodimerization 
as well as heterodimerization with other C/EBP family members. An N-ter-
minal transactivation domain presumably functions through interactions with 
the transcription machinery. The three isoforms of C/EBP, α, β, and δ, can het-
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erodimerize with one another, bind to similar DNA elements, and transacti-
vate reporter constructs containing C/EBP elements (79). 
C/EBPα (expressed in liver, adipocytes, and proliferating myelomono-
blasts) coordinates transcriptional activation of groups of genes (11). Al-
though C/EBPα can induce the expression of PPARγ in 3T3-L1 cells, homodi-
mers of C/EBPβ are the primary inducers of PPARγ expression. Both C/EBPβ 
and C/EBPδ are necessary but not sufficient for transcriptional activation of 
C/EBPα (127). 
Insulin reciprocally regulates the transcription of C/EBP genes in adipo-
cytes (70). Treatment of 3T3-L1 adipocytes with insulin inhibits repression 
of transcription of the C/EBPα gene. In contrast, insulin treatment rapidly, but 
transiently, induces the expression of C/EBPβ and C/EBPδ. Therefore, an in-
crease in insulin level decreases gene expression from promoters with C/EBP-
binding sites. 
Dietary Control of FABP Expression 
The nutritional state of an organism significantly affects FABP expression. 
For example, following a 2–3 day fast, liver FABP mRNA decreases 30–70% 
in the liver (6); conversely, heart FABP is induced twofold in red skeletal mus-
cle (14). On a low-fat diet, levels of liver FABP and intestinal FABP mRNA 
in the intestine decrease, whereas liver FABP mRNA levels remain constant 
in the liver (51). Levels of liver FABP in hepatic tissue, normally higher in fe-
male than in male mice (4, 7, 80, 85), became similar upon a low-fat diet. In 
contrast, a high-fat meal results in a nearly twofold increase in liver FABP 
and intestinal FABP (4, 81). In cell culture systems, free fatty acids upregulate 
liver FABP expression (19). In addition, long-chain fatty acids rapidly induce 
the expression of adipocyte LBP in a variety of preadipocyte cell lines (24). 
Therefore, dietary factors, including intake of lipids and fatty acids, affect the 
abundance of the FABPs. 
Regulation of FABP Genes 
ADIPOCYTE LIPID-BINDING PROTEIN (AP2) GENE The adipocyte LBP gene, aP2, 
is regulated predominantly during the course of adipose conversion as 
cells differentiate from a fibroblastic precursor cell to a mature adipocyte. 
Identification of the proteins regulating the increase in expression and the se-
quence elements to which they bind was facilitated by comparison of the pro-
moter regions of genes induced during adipocyte differentiation (Figure 2). 
Fat-specific element 2, bound by a c-fos/c-jun complex, activates transcrip-
tion of aP2 (89). This sequence, also called AP-1, overlaps a negative regula-
tory element involved in the control of aP2 expression in preadipocytes. Glu-
cocorticoids positively regulate aP2 expression, presumably via a response 
element identified by sequence analysis at position −393 to −385 (21). 
C/EBPα involvement has been demonstrated in the regulation of many 
genes that encode proteins of intermediary metabolism. In the promoter re-
gion of aP2, C/EBPα binds at −149 to −130 and is a major contributor to the 
regulation of gene expression in the mature fat cell (16). Adipocyte response 
element 1 (ARE, located at −5.3 kb) is bound by nuclear factor 1 (31). Mu-
tation of this sequence significantly reduced the activation of aP2. ARE2 and 
ARE4 (located at approximately −5.2 kb) are two elements that are bound by 
ARF2 (adipose regulatory factor 2), and stimulate transcription (32). In cells 
in culture, mutation of either site decreases aP2 expression by approximately 
90%. 
In cell culture, 168 bases of upstream sequence conferred differentiation-
dependent expression on linked heterologous promoters. However, neither 
this nor a larger construct (including 1.7 kb) could direct appropriate expres-
sion in transgenic mice. Subsequently, an enhancer was discovered, mapping 
at −5.4 kb and −4.9 kb (94). The enhancer alone is necessary and sufficient 
to direct adipocyte-specific expression of a reporter gene in transgenic mice. 
Within this sequence is a PPRE (DR-1 element) capable of being bound by 
the heterodimer PPARγ 2/RXRα (117). The strict tissue-specific expression of 
aP2 in adipocytes may be caused by PPAR, which has an expression similar 
to that of aP2. The involvement of a PPAR is consistent with the observation 
that thiazolidinediones increase aP2 mRNA levels (34). Fatty acids transcrip-
tionally regulate aP2 in preadipocytes but not in mature fat cells to any extent 
(24). This observation suggests that in adipocytes, where high levels of adi-
pocyte LBP are present, fatty acids may be relatively ineffective as transcrip-
tional regulators. In summary, many proteins are involved in the regulation of 
aP2 expression, including C/EBPα and PPARγ 2. 
INTESTINAL FATTY ACID–BINDING PROTEIN GENE Sequence analysis of the 5´ non-
transcribed regions of the intestinal FABP genes from mice, rats, and humans 
indicated three highly conserved domains (112). Intestinal FABP is expressed 
only in the intestine in a complex pattern of gradients: vertical from crypt to 
villus and horizontal from duodenum to colon (20). Reporter constructs in 
transgenic mice demonstrated that the first 227 bases upstream of the start of 
transcription were capable of directing expression to the small intestine and 
displaying the appropriate villus-to-crypt gradient (113). However, 1.1 kb of 
sequence is necessary to add the proximal-to-distal pattern as well as to ac-
quire normal levels of expression. The sequence −212 to −188 binds a colon-
derived factor and is located within a region important to the suppression of 
ileal and colonic expression (20). 
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DNase I footprinting experiments using C/EBPα resulted in protection of 
bases −188 to −167, located within the second of the three conserved domains 
of the intestinal FABP promoter (20). A construct containing a C/EBP-binding 
site and one DR-1 element was capable of directing expression of intestinal 
FABP to the intestine in transgenic animals (20). This DR-1 element is one of 
three found in the intestinal FABP promoter (33, 97). The first element binds 
a nuclear hormone receptor, ARP-1 (95). Although peroxisome proliferators 
have only minimal effects on the expression of intestinal FABP, PPAR/RXR 
heterodimers may bind to these elements and activate transcription. As with 
other FABPs, C/EBPs and perhaps PPARs appear to be involved in the regu-
lation and tissue-specific expression of intestinal FABP (Figure 2). 
LIVER FATTY ACID–BINDING PROTEIN GENE Liver FABP is expressed abundantly 
in the liver (2–5% of cytosolic protein), and in a gradient similar to intestinal 
FABP in the intestine (declining gradient from the jejunum to ileum and from 
villus tips to crypt cells of villi; 5). Four kilobases of the upstream region of 
the liver FABP promotor are sufficient to correctly direct expression of a re-
porter gene in the hepatocyte. Such a construct is expressed in the horizontal, 
but not the vertical, gradient in the intestine (111). Sequences between −4.0 
and −0.6 kb are required for suppression of liver FABP expression in the co-
lon and kidney (106). 
Both high-fat diets and peroxisome proliferators increase the abundance of 
liver FABP in the liver and intestine (52). Consistent with these observations, 
the rat liver FABP gene contains an imperfect PPRE at −76 to −66 kb (106). 
This sequence confers responsiveness to peroxisome proliferators in the pres-
ence of PPARα (47). DNase I footprinting with C/EBPα results in the protec-
tion of three distinct regions (20, 65). Therefore, similar to aP2 and intestinal 
FABP, the liver FABP promoter contains sequences responsive to both C/
EBPs and PPARs (Figure 2). Unlike other FABPs, liver FABP is able to bind 
to peroxisome proliferators, which may play a role in regulating the availabil-
ity of ligands for PPARs (13). 
KERATINOCYTE LIPID-BINDING PROTEIN GENE Keratinocyte LBP (formerly called 
mal-1) was identified as an mRNA that was increased in abundance in murine 
benign papillomas and malignant squamous-cell carcinoma of skin (60). Ex-
pression of keratinocyte LBP mRNA is low in normal skin, tongue, lung, and 
mammary tissue gland. Elevated levels were detected in SV40-transformed 
fibroblasts and fibroblasts transformed by other tumor viruses. The rat homo-
log is highly expressed in lens epithelial cells (124). Keratinocyte LBP is the 
first lipid-binding protein to show high levels of induced expression without 
concomitant cellular differentiation. Many transformed cells contain altered 
types and quantities of lipids in comparison to wild-type cells. Since fatty ac-
ids regulate other FABPs, it is reasonable to hypothesize that keratinocyte 
LBP may respond similarly, perhaps through a PPAR. 
In fat cells, the predominant FABP is adipocyte LBP. However, keratino-
cyte LBP can be detected at very low levels. Spiegelman and colleagues (42) 
have developed a line of transgenic mice with a targeted disruption of the aP2 
allele. Such animals are fertile, developmentally normal, and phenotypically 
indistinguishable from heterozygous littermates. As a result of the aP2 disrup-
tion, keratinocyte LBP is induced 40-and 14-fold at the levels of mRNA and 
protein, respectively (N Ribarik Coe, AV Hertzel, DA Bernlohr, manuscript 
in preparation). Therefore, the lack of aP2 expression is compensated par-
tially by an increase in keratinocyte LBP expression. Consistent with a role of 
fatty acids in the regulation of these FABPs, the free fatty acid levels are ele-
vated in adipocytes from transgenic mice null for adipocyte LBP. The altered 
intracellular lipid levels may be indicative of metabolic differences between 
wild-type and aP2 disruptants. When wild-type animals are fed a high-fat diet 
(40% fat calories), diet-induced obesity leads to elevated blood glucose lev-
els, insulin resistance, and overexpression of tumor necrosis factor-α (TNF-
α). TNF-α indirectly inhibits the tyrosine kinase activity of the insulin recep-
tor, thereby leading to insulin resistance (41). Interestingly, on a high-fat diet, 
aP2 null mice had normal blood glucose levels, remained insulin sensitive, 
and lacked TNF-α. The observation that elevated dietary fat does not lead to 
insulin resistance in aP2 null mice suggests a role for adipocyte LBP in insu-
lin action (42). 
CONSERVED ELEMENTS OF THE FABP FOLD 
Evolutionary preservation of gene structure between its members is one 
reason why the fatty acid–binding proteins are classified as a multigene fam-
ily. Their overall degrees of nucleotide similarity translate to protein pri-
mary sequences ranging in identity from 20 to 70% (Figure 3). Despite such 
wide variability in amino acid conservation, crystal structures obtained for 
numerous family members have demonstrated a characteristic, superimpos-
able structural arrangement that includes several noteworthy features (22, 99, 
128–131). 
Measurements of circular dichroism exhibited by the FABPs gave the first 
indications of the predominance of β-sheets in the folded protein. Crystal-
lographic analysis indicates the structure is roughly 70% β-sheet conforma-
tion. Its topology is relatively simple: ten antiparallel β-strands each hydro-
gen-bonded to the adjacent strand to form two β-sheets that then fold to adopt 
the shape of a barrel (Figure 4). The two sheets are virtually perpendicular to 
each other, enabling the first and last β-strands to hydrogen bond and close the 
barrel, thus flattening it slightly into what has been described as a β-clam (96). 
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The β-strands are interconnected by short loops, each of which contains only 
a few amino acids. Between the first and second β-strands two α-helices ar-
ranged in a helix-turn-helix motif loop out to cover the mouth of the barrel. 
The base of the barrel is filled by side-chains. Located within the barrel is the 
large water-filled ligand-binding cavity of about 400–600 Å3 (approximately 
2-to 3-fold in excess of the volume required to hold its ligand and 5–10% 
of the total protein volume). The cavity wall is lined with amino acid side-
chains, roughly 50% of which are charged or polar residues (3). 
As a result of the flattening of the barrel, one pair of adjacent β-strands is 
unable to hydrogen bond. There is a gap between strands βD and βE because 
of the absence of main-chain hydrogen bonding. In this region the two strands 
are oriented such that their side-chains fill much of the interstrand space. Crys-
tallographically ordered water molecules fill the remainder (3). This gap may 
result from a preferred folding pathway as dictated by the hydrophobic back-
bone. The gap is likely to contribute flexibility to the folded structure, in the 
sense that it could physically facilitate an opening and closing around larger 
ligands, and that the same tertiary structure can be formed despite such vary-
ing primary structure. 
Space-filling models of the FABPs reveal few sites through which the 
binding cavity is accessible to solvent, and none in the static structure with 
sufficient dimensions to permit ligand entry. Thus, the region most likely to 
Figure 4 Ribbon diagram of adipocyte LBP apoprotein demonstrating characteristic features of 
the FABP fold as described in the text. The 10 antiparallel β-strands are labeled βA through βJ. 
The α-helices are numbered I and II. Reprinted from Reference 128 with permission from the 
American Chemical Society. 
Figure 3 Alignment of the amino acid sequences from representative members of each class of 
FABP. Dots indicate gaps inserted to optimize alignment. Sequences listed are murine except 
where indicated below. The 21 sequences are adipocyte LBP (ALBP), myelin P2 (P2), keratinocyte 
LBP (KLBP), human psoriasis-associated FABP (PAFABP), bovine lens LP2 (LP2), heart FABP 
(HFABP), brain FABP (BFABP), chick retina (RFABP), rat testis (TLBP), intestinal enterocytes 
of rat (IFABP, IBABP) or pig (ILBP), liver FABP (LFABP), shark liver FABP(ShkFABP), human 
blood fluke Schistosoma japonicum FABP (SjFABP), blood fluke Schistosoma mansoni (Sm14), 
liver fluke Fasciola hepatica (Fh15), and larvae of the moth Manduca sexta (MFB1, MFB2). 
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serve as a ligand portal has been deduced by the small amount of exposed 
area observable in crystal structures, by its greater mobility (higher B-fac-
tors), by its differential sensitivity to proteases in the bound vs unbound state 
(49), and by the effect of mutations to that region upon binding affinities/ki-
netics (17, 37, 56). The portal is gated by the helix-turn-helix motif and inter-
strand loops βC-to-βD and βE-to-βF. Additional support derives from compar-
isons of apo-vs holostructures (i.e. unliganded vs ligand bound) in which the 
only conformational differences occur in that region (98, 128). Furthermore, 
the terminal methyl carbon of oleate protrudes slightly from the small surface 
opening (129, 130). 
One theory describing probable forces driving protein folding predicts 
an initial nonspecific collapse preceding the formation of organized tertiary 
structure. Such a collapse is nucleated by interactions between specific non-
polar amino acids that form a hydrophobic core. Searches for motifs of this 
kind in the intracellular LBP structures have highlighted a series of primar-
ily nonconsecutive hydrophobic residues that are conserved between family 
members (3). These residues cluster to generate a hydrophobic backbone that 
may be partly responsible for the basic intracellular LBP fold. 
Several of the intracellular LBP crystal structures have been refined 
sufficiently to assign coordinates not only to the expected covalent atoms of 
the protein and/or bound ligand but also to noncovalently held water mole-
cules (98, 129, 130). These crystallographically ordered waters are conserved 
between apo-and holo-structures of the same protein, and to some degree, be-
tween proteins. Some of them, as mentioned above, fill portions of the gap not 
occupied by side-chain atoms. About ten conserved waters are located within 
the cavity such that they form part of the ligand contact site. The conserved 
water and polar side-chains are present in the cavity presumably to stabilize 
the structure of the protein and to preserve the central ligand cavity. Bound 
water may present an attractive force for the acyl tail by taking on a nonpolar 
character in the tightly bound state. 
FUNCTIONAL ANALYSIS OF THE FABPs 
FABPs, as suggested by the name, generally exhibit a preference for fatty 
acids. More specifically, only long-chain fatty acids will bind FABPs with 
measurable affinity. Each protein molecule will bind and sequester within its 
cavity a single hydrophobic ligand. The exception to this is the liver FABP, 
which is capable of binding two fatty acids (121). 
Affinity for fatty acids appears to be related to chain length, since 16–20 
carbon fatty acids have the lowest dissociation constants. Degree of satura-
tion may play a role: Systematic comparison of the binding properties of sev-
eral FABPs established a correlation between the number of double bonds and 
affinity (91). For certain FABPs, such as liver FABP, affinity decreased with in-
creasing unsaturation. However, for adipocyte LBP, no discrimination in bind-
ing between saturated and unsaturated fatty acids was noted. The effect may 
arise from the inherent aqueous solubility of the ligand itself, or the number of 
polar vs nonpolar cavity contacts with bound ligand, or possibly the degree of 
conformational restraint imposed upon the bound ligand by its cavity contacts. 
Specificity for ligands in vitro shows some variation among FABP types 
(Table 2). Heart, adipocyte, intestinal, keratinocyte, brain, testis, myelin P2, 
and liver FABPs are all able to bind tightly to long-chain fatty acids. Adipo-
cyte (MA Simpson, DA Bernlohr, unpublished results) and keratinocyte (55) 
LBPs are both able to bind oxidized lipid species such as hydroxy-and hy-
droperoxyeicosatetraenoic acids (HETEs and HPETEs), but their affinities for 
leukotrienes and prostaglandins are negligible. Ileal FABP (97) and intesti-
nal bile acid– binding protein (28) both form high-affinity complexes with 
bile acids. Liver FABP, as previously mentioned, can bind either one or two 
long-chain fatty acids, but its ligands also include heme, steroids, acyl CoAs, 
oxidized/peroxidized fatty acids, leukotrienes, prostaglandins (90), and per-
oxisome proliferators (108). Brain FABP associates with fatty acids and acyl 
CoAs (76). 
Besides long-chain fatty acids and other physiological lipids, many of the 
FABPs bind fluorescent or sulfonated analogs of fatty acids such as hexa-
decanesulfonate (63), 1-anilino-8-naphthalenesulfonate (1,8-ANS; 54), 12-
(9anthroyloxy)oleate (12-AO; 104), 2-(9-anthroyloxy)palmitate (2-AP; 37), 
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and cis-parinaric acid (cPA; 76, 104). Such ligands are particularly useful in 
designing assays to evaluate affinity and/or specificity of native ligands. 
Numerous crystal structures have been solved in order to study the pro-
tein-lipid interactions that determine ligand affinity and specificity on a mo-
lecular level. High-resolution crystal structures are available for intestinal 
(99), muscle (heart; 130, 131), myelin P2 (22), and adipocyte (63, 64, 128, 
129) FABPs in the absence and presence of various ligands. Examination and 
comparison of tertiary structures of the holoprotein, in conjunction with pri-
mary sequence information, pinpointed three conserved residues that con-
stitute a fatty acid– binding motif. Though the precise conformation of the 
hydrocarbon tail varies, similar positions relative to these residues were ob-
served for all structures. As shown in Figure 5, the bound ligand is oriented 
such that its negatively charged carboxylate engages in electrostatic-and hy-
drogen-bonding interactions with two arginines (one via a conserved, crystal-
lographically ordered water) and a tyrosine located at the base of the cavity, 
opposite the portal. The tail of the lipid flattens against the wall of the cavity 
and either projects with a single bend toward the portal, as observed for adi-
pocyte LBP binding to oleate, stearate (129), and palmitate (63), or settles into 
a U-shape as occurs in heart FABP (130) and adipocyte LBP with bound ara-
chidonate (64). This triad is not preserved in liver, ileal, and intestinal FABPs, 
nor in cellular retinol binding proteins I and II (3). The liver and ileal proteins 
have broader ligand-binding specificities than most FABPs. Intestinal FABP, 
although specific for binding to long-chain fatty acids, retains only a single ar-
ginine from the triad motif (99). Cellular retinol binding proteins I and II uti-
lize glutamine at the analogous position to accept a hydrogen bond from the 
hydroxyl head group of retinol (22, 126). 
Nuclear magnetic resonance (NMR) studies indicated that the carboxyl-
ate of ligands bound to intestinal FABP was buried in the cavity, was non-ion-
izable, and that the signals normally obtained from the single conserved ar-
ginine at the base of the cavity were variable with the presence or absence 
of a bound ligand (18). NMR data also indicated that ileal (97) and liver (18) 
FABPs may bind ligands similarly to each other. Fatty acid carboxylates were 
ionizable, indicating solvent accessibility, and were oriented toward the sur-
face of the binding protein. This orientation is opposite that found for intesti-
nal FABP and most other family members. 
The importance of the FABP triad was established for adipocyte LBP by 
mutagenizing two of its conserved residues, R126 and Y128, to leucine and 
phenylalanine, respectively (104). These mutations maintained essentially 
similar size and shape characteristics but eliminated hydrogen-bonding and 
charge-neutralization capabilities. The mutant protein was no longer able to 
bind the fluorescent fatty acid analog cis-parinaric acid, nor would it adhere 
to a long-chain fatty acid affinity column (MA Simpson, DA Bernlohr, unpub-
lished results). 
Mutagenesis of the intestinal FABP’s conserved arginine was sufficient to 
disrupt fatty acid binding as assessed by NMR and titration calorimetry (48). 
Furthermore, conversion of this residue to glutamine, as found in the analo-
gous position in cellular retinol binding protein II, converted intestinal FABP 
to a retinol-binding protein. Hence, in this family member, a specific arginine 
seems to influence ligand specificity. 
In contrast, mutation of the analogous arginine 122 residue in liver FABP 
altered only slightly the protein’s affinity for fatty acids (116). Instead, its 
affinity for acyl CoA ligands was increased. Ligands bound to liver FABP may 
have a greater number of nonpolar cavity contacts than ligands bound to other 
FABPs. Hydrophobic interactions would then contribute more significantly to 
binding energy than would electrostatics. 
Energetic Considerations 
Titration calorimetry is a technique by which stoichiometry, affinity, and 
heat of reaction (enthalpy) may be determined simultaneously for a binding 
Figure 5 The FABP fatty acid–binding triad and its interactions with the carboxylate of a bound 
ligand. Depicted are amino acids representing adipocyte LBP residues R106, R126, and Y128, as 
positioned when bound to stearate. Dotted lines indicate hydrogen bonding. Open symbols repre-
sent oxygen, stippled symbols nitrogen, and filled symbols carbon atoms. 
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interaction. With this information, the free energy and entropy of binding are 
then also calculable. Measurements of this kind have been conducted on ad-
ipocyte and intestinal FABPs with various ligands (48, 61, 64, 73). Dissoci-
ation constants obtained in these studies are approximately an order of mag-
nitude larger than those assessed using fluorescent probes such as 1,8-ANS 
(54) and ADIFAB (acrylodan-derivatized intestinal FABP; 91). The acrylodan 
moiety displays a fluorescence red shift upon ligand binding, which permits 
quantitation of free ligand. This probe can then be used to determine binding 
constants for any ligand to any FABP by using a competition assay. Compar-
ison of ADIFAB dissociation constants (Kd) measured at different tempera-
tures yields an alternative enthalpy determination via the van’t Hoff equation. 
Despite differences in absolute dissociation constants, which probably arise 
because of incorrect reference heat subtractions in the older calorimetric mea-
surements (61), the same conclusions are ultimately derived from the data and 
represent consistent information about forces critical to binding. In general, 
the affinities of fatty acids for FABPs range from 10 to 1000 nM. 
Electrostatic interactions consist of charge neutralizations, hydrogen 
bonding, and London dispersion forces (van der Waals interactions). These 
interactions contribute primarily to the enthalpy of binding. Thermodynamic 
measurements have determined that under physiological conditions, a large 
negative enthalpy (i.e. an exothermic reaction) is the major driving force for 
the binding reaction. Large enthalpic factors arise from the polar interactions 
at the carboxylate, as well as the temporary induced dipoles generated be-
tween the long hydrocarbon tail and its cavity contacts. This latter factor, the 
van der Waals interaction, partially explains the specificity of FABPs for long-
chain fatty acids since there is more potential for cavity contact and, there-
fore, attractive forces. 
A small entropic component also contributes to binding energetics. En-
tropy of binding results from the net balance of unfavorable entropy intro-
duced by the protein constraining the free ligand to a rigidly bound state and 
the favorable release of water molecules that formerly were ordered around 
the lipid. Therefore, saturated ligands may exhibit a greater positive entropic 
effect because of their lower aqueous solubility and the greater amount of dis-
order that arises when they are removed from solvent. 
Recent studies focusing on the kinetic aspects of ligand binding have af-
forded further physical knowledge about FABP ligand-binding processes. Us-
ing a more sensitive mutant of the fluorescent probe ADIFAB, Richieri et 
al (92) have compared on-and off-rates for adipocyte, heart, and intestinal 
FABPs. The adipocyte protein had the lowest rate constant for ligand bind-
ing (kon) and the highest rate of dissociation (koff) for palmitate, oleate, lino-
leate, linolenate, and arachidonate. Variability in affinities between proteins 
and different ligands resulted primarily from differences in koff. Support for 
involvement of the portal derives from a recent study of a variant of intesti-
nal FABP that lacks the helix-turn-helix cap (17, 56). This mutant folded cor-
rectly, with some loss of stability (56), and had diminished affinity for fatty 
acids that was attributed primarily to an increase in ligand off-rate, while kon 
remained unchanged (17). Hence, it seems that ligand binding to FABPs, tra-
ditionally considered a two-state process involving only bound or free pro-
tein, may transpire via passage through one or more intermediate states. 
Kinetic studies have been used for several years to define the putative in-
teractions that might govern transfer of ligands from FABPs to cellular mem-
branes (110). In these experiments, a FABP (heart, adipocyte, liver, or in-
testinal) was loaded with a fluorescent fatty acid analog and incubated with 
phospholipid vesicles of defined composition. Transfer was measured as a 
fluorescence decrease when the fatty acid analog entered the vesicle mem-
brane. The rate of transfer from the adipocyte, heart, and intestinal FABP de-
pended on phospholipid composition and vesicle concentration. This observa-
tion indicates that collision of the protein with the membrane is required for 
lipid transfer (37, 38). Transfer from liver FABP occurs independently of ei-
ther phospholipid composition or vesicle concentration and so is defined as 
diffusional (43). Global acetylation of surface lysine residues of both heart 
and adipocyte FABPs altered the kinetics of transfer to a diffusional mecha-
nism and abolished the tendency of both proteins to transfer lipids more rap-
idly to negatively charged vesicles (37, 38), implicating the lysines in a piv-
otal role as collisional modulators. Mutants of heart FABP were constructed 
that neutralized the lysines at the portal and at regions remote from the portal 
(37). Only the neutralized portal lysines affected the transfer mechanism. The 
different mechanisms are particularly interesting in intestinal enterocytes, in 
which both liver and intestinal FABPs are found, implying that each may have 
a specialized function. 
HYPOTHESES CONCERNING FABP FUNCTIONS 
Fatty acid–binding proteins have been studied for 25 years. Despite our 
understanding of the biophysics and molecular genetics of fatty acid–bind-
ing proteins, questions remain surrounding their function. X-ray and NMR 
structures have provided a wealth of information concerning the physical fac-
tors that contribute to ligand binding affinity and specificity. Although trans-
genic animal studies have been informative, they have not yielded definitive 
conclusions concerning the physiological function and role of FABPs in lipid 
metabolism. 
One suggested role for FABPs is sequestration of fatty acids within the cy-
tosol. FABPs may serve as intracellular buffers for fatty acids, protecting cells 
from deleterious effects of excess free fatty acids by sequestering them in-
side the ligand cavity. This could include a more specific role in scavenging 
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of potentially mutagenic reactive lipid species, particularly in the case of liver 
FABP and keratinocyte LBP. 
FABPs are probably also involved in shuttling fatty acids within the cy-
tosol and delivering them to specific enzyme/protein systems. They may fa-
cilitate fatty acid uptake/efflux through the plasma membrane and delivery to 
or export from intracellular organelles. This function could also modulate the 
fatty acid– sensitive acitivities of some enzymes. A related role is the possible 
delivery of lipids to the nucleus, where they may become cofactors for gene 
expression mediated by PPARs. In fact, liver FABP translocates from the cy-
tosol to the nucleus in response to ligand binding (108). 
Support for the importance of FABPs in uptake and metabolism of fatty 
acids derives from studies of the Pima Indians of Arizona. The Pima popula-
tion has an enhanced predisposition to type II diabetes [non-insulin–depen-
dent diabetes mellitus (NIDDM)] (115). A polymorphism in intestinal FABP 
segregates with the disease state, manifested by increased lipid oxidation 
and development of obesity and insulin resistance (2). The allele, which en-
codes a substitution of alanine 54 to threonine, occurs at a frequency of 30% 
within the Pima tribe. In vitro, A54T intestinal FABP binds fatty acids twice 
as tightly as the wild type. Expression of A54T intestinal FABP in the intesti-
nal epithelial cell line, Caco2, resulted in increased fatty acid uptake and tri-
acylglycerol secretion by these cells (1). Since elevated plasma triacylglycer-
ols are linked to development of insulin resistance, the A54T intestinal FABP 
polymorphism could account for the prevalence of insulin resistance in the 
Pima Indians. 
It is clear that nutritionally derived fatty acids are bound by intracellular 
fatty acid–binding proteins (122a). As more negative effects of dietary fat are 
revealed, understanding the structure, function, and regulation of cellular lipid 
carriers becomes increasingly important. Clues to the involvement of FABP 
function in metabolism of dietary lipids come from analysis of altered genetic 
states, such as that observed in the Pima Indians or mice null for aP2. In the 
Pimas, increased lipid uptake and binding conferred by the intestinal FABP 
A54T polymorphism correlates with enhanced prevalence of NIDDM, while 
mice lacking adipocyte LBP maintain insulin sensitivity. As we learn more 
about the roles of different FABPs, other metabolic processes central to nutri-
tion and human health will likely be uncovered. 
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